Zentalis Pharmaceuticals Inc. (ZNTL): Price and Financial Metrics

Zentalis Pharmaceuticals Inc. (ZNTL): $3.32

0.59 (+21.61%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add ZNTL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#124 of 328

in industry

ZNTL Price/Volume Stats

Current price $3.32 52-week high $18.24
Prev. close $2.73 52-week low $2.66
Day low $2.71 Volume 2,861,200
Day high $3.34 Avg. volume 1,318,230
50-day MA $3.30 Dividend yield N/A
200-day MA $8.35 Market Cap 236.08M

ZNTL Stock Price Chart Interactive Chart >


Zentalis Pharmaceuticals Inc. (ZNTL) Company Bio


Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin D. Bunker on December 23, 2014 and is headquartered in New York, NY.


ZNTL Latest News Stream


Event/Time News Detail
Loading, please wait...

ZNTL Latest Social Stream


Loading social stream, please wait...

View Full ZNTL Social Stream

ZNTL Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!